Global Green Announces Extension Of Agreement With Merial For Evaluation Of Salmonella Vaccine And License Option

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Global Green, Inc. (OTCBB:GOGC), a green bio-pharmaceutical company, announces today the 90-day extension of an existing agreement with Merial Ltd., the Animal Health Division of Sanofi. The extension to the agreement initially announced on September 4, 2013, will allow time for the completion of the internal evaluation of Global Green’s patented Salmogenics vaccine technology. At the conclusion of the evaluation, Merial has the first option to enter into a license agreement with Global Green for the manufacture, distribution, and sale of the vaccine. Details of the evaluation agreement are confidential.

Help employers find you! Check out all the jobs and post your resume.

Back to news